The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

A beginner's guide to R.

Bedogni G.

Journal of The Royal Statistical Society: SeriesA, July;173:697

2010

Clinical Prediction Models: a practical approach to development, validation and updating

Bedogni G.

Journal of The Royal Statistical Society: Series A;172:944 (Book review)

2009

Statistical models: theory and practice (revised edition)

Bedogni G.

Significance ;4:188 (Book review).

2009

Modern Regression Methods

Bedogni G.

Journal of The Royal Statistical Society: Series A; 6:275 (Book review).

2009

Biochemical investigations in the management of liver disease

Rigato I, Ostrow JD and Tiribelli C
In "Textbook of Hepatology: From Basic Science to Clinical Practice" 3rd Edition. Edited by Juan Rodés, Jean-Pierre Benhamou, Andres Blei, Jurg Reichen and Mario Rizzetto. Backwel Publisdhing, Oxford, UK N° [Pag. ]
2007

Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children

P.Brambilla, G. Bedogni, LA Moreno, MI Goran, B Gutin, KR Fox, DM Peters, P Barbeau, M De Simone and A Pietrobelli.
International Journal of Obesity N°30 [Pag. 23-30]
2006

The assessment of body composition in health and disease

Bedogni G, Brambilla P, Bellentani S, Tiribelli C.
Human Ecology Special Issue (Kaushik Bose, Guest Editor) N°14 [Pag. 21-25]
2006

Disturbances of bilirubin metabolism

Cekic D, Rigato I, and Tiribelli C.
In "Clinical Gastroenterology and Hepatology". By: WM Weinstein, CJ Hawkey, J Bosch Eds. Elsevier Mosby, Philadelphia, USA. N° [Pag. 693-698]
2005

Metabolismo y alteraciones de la bilirrubina

Bayon JE, Pascolo L, and Tiribelli C.
In: Conceptos actuales en hepatologia. By: Mendez-Sanchez N and Uribe M Ed.Masson Doyma, Mexico N° [Pag. 71-81]
2003

Alcohol and Nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, and Bedogni G.
In: "Nutrition and Alcohol: Linking Nutrient Interactions and Dietary Intake"By: RR Watson and VR Preedy Ed. CRC Press, Boca Raton, FL, USA N° [Pag. 73-85]
2003

Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial

D'Auria E, Panelli S, Lunardon L, Pajoro M, Paradiso L, Beretta S, Loretelli C, Tosi D, Perini M, Bedogni G, Abdelsalam A, Fiorina P, Bandi C, Zuccotti GV

 Pharmacol Res. 105284. doi: 10.1016/j.phrs.2020.105284.

2020

Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients

Pascut D, Pratama MY, Gilardi F, Giuffrè M, Crocè LS, Tiribelli C.

Sci Rep. 10(1):18967. doi: 10.1038/s41598-020-75945-2.

2020

The extent of intracellular accumulation of bilirubin determines its anti- or prooxidant effect

Bianco A, Dvořák A, Capková N, Gironde C, Tiribelli C, Furger C, Vitek L, Bellarosa C

Int J Mol Sci. 21(21):E8101. doi: 10.3390/ijms21218101.

2020

Spontaneous rectal perforation in a patient with SARS-CoV-2 infection

Giuffrè M, Bozzato AM, Di Bella S, Occhipinti AA, Martingano P, Cavallaro MFM, Luzzati R, Monica F, Cova MA, Crocè LS

J Pers Med. 10(4):E157. doi: 10.3390/jpm10040157.

2020

Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery

Giuffrè M, Giuricin M, Bonazza D, Rosso N, Giraudi PJ, Masutti F, Palmucci S, Basile A, Zanconati F, de Manzini N, Tiribelli C, Palmisano S, Crocè LS.

Diagnostics. 10(10):795. doi: 10.3390/diagnostics10100795

2020

Circulatory miRNA as biomarker for therapy response and disease-free survival in Hepatocellular Carcinoma

Pascut D, Pratama MY, Gilardi F, Giuffrè M, Crocè LS, Tiribelli C

Cancers. Sep 29;12(10):2810. doi: 10.3390/cancers12102810.

2020

Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery

Giraudi P, Giuricin M, Bonazza D, de Manzini N, Tiribelli C, Palmisano S, Rosso N

Int J Obes (Lond). 2020 Sep 17. doi: 10.1038/s41366-020-00687-0

2020

COVID-19-induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19

M Giuffrè, S Di Bella, G Sambataro, V Zerbato, M Cavallaro, AA Occhipinti, A Palermo, A Crescenti, F Monica, R Luzzati, LS Crocè

Trop Med Infect Dis. 2020 Sep 16;5(3):E147. doi: 10.3390/tropicalmed5030147.

2020

The model for early COVID-19 recognition (MECOR) score: A proof-of-concept for a simple and low-cost tool to recognize a possible viral etiology in community-acquired pneumonia patients during COVID-19 outbreak

Sambataro G, Giuffrè M, Sambataro D, Palermo A, Vignigni G, Cesareo R, Crimi N, Torrisi SE, Vancheri C, Malatino L, Colaci M, Del Papa N, Pignataro F, Roman-Pognuz E, Fabbiani M, Montagnani F, Cassol C, Cavagna L, Zuccaro V, Zerbato V, Maurel C, Luzzati R, Di Bella S

Diagnostics (Basel)  2020 Aug 21;10(9):E619doi: 103390/diagnostics10090619

2020

Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension

Giuffrè M, Bedogni G, Abazia C, Masutti F, Tiribelli C, Crocè LS

Ann Hepatol 2020 Aug 20:S1665-2681(20)30077-6 doi: 101016/jaohep202007004

2020

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.

2017

Treatments for non-alcoholic steatohepatitis - still a long way to go

 Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)

2017

Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice

Moretti R, Caruso P, Crisman E, Gazzin S

Neurol India. Jul-Aug;65(4):814-825. doi: 10.4103/neuroindia.NI_850_16

2017

Is it time to change NAFLD and NASH nomenclature?

Bellentani S, Tiribelli C

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):547-548. doi: 10.1016/S2468-1253(17)30146-2

2017

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health

Martini D, Rossi S, Biasini B, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Di Nuzzo S, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Del Rio D

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):473-503. doi: 10.1016/j.numecd.2017.01.008. Epub 2017 Feb 13

2017

The molecular basis of jaundice: An old symptom revisited

Gazzin S, Masutti F, Vitek L, Tiribelli C

Liver Int. doi: 10.1111/liv.13351.

2016